Paul Berg II @geenguru.bsky.social Biotech researcher turned market nerd, passionate about the science behind the stock.- D Dmitry Kovalchuk @dmitrykovalchuk.bsky.social All things stock markets with a strong interest in biotech and natural resources.
Jacob Plieth @jacobplieth.bsky.social Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Scott Gottlieb, MD @scottgottliebmd.bsky.social Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Boards: Pfizer, Illumina, TempusAI, United Health
Endpoints News @endpts.com We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com. 
Drew Armstrong @drewsnews.bsky.social Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky
Priors: Bloomberg News + the Covid vaccine tracker. CQ.
Adam Feuerstein✡️ @adamfeuerstein.bsky.social Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
Emily Mullin @emilymullin.bsky.social Staff writer @wired.com covering health+biotech. Uses em dashes without AI.
Author page: https://www.wired.com/author/emily-mullin/
Email: emily_mullin@wired.com
Signal: emullin.06
Lisa Jarvis @lisamjarvis.bsky.social Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
Bluesky @bsky.app official Bluesky account (check username👆)
Bugs, feature requests, feedback: support@bsky.app